Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2018
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLCDavid R Spigel, Jamie E Chaft, Scott Gettinger, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trialChiara Dauccia, Maria Alice Franzoi, Cristina Saura, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2018
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumorsColin D Weekes, Lee S Rosen, Anna Capasso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2023
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast CancerSarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo, et al.
JACC. Cardiovascular Imaging|January 12, 2015
Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humansHamed Emami, Parmanand Singh, Megan MacNabb, et al.
Investigational New Drugs|April 26, 2019
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumorsGeoffrey I Shapiro, Patricia LoRusso, Eunice Kwak, et al.
Breast Cancer Research and Treatment|November 19, 2022
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancerAditya Bardia, Ingrid Mayer, Eric Winer, et al.
International Journal of Cardiology|May 3, 2016
Treatment with a human recombinant monoclonal IgG antibody against oxidized LDL in atherosclerosis-prone pigs reduces cathepsin S in coronary lesionsChristian Bo Poulsen, Ahmed Ludvigsen Al-Mashhadi, Karin von Wachenfeldt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumorsDebashis Sarker, Joo Ern Ang, Richard Baird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2023
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast CancerKomal L Jhaveri, Meritxell Bellet, Nicholas C Turner, et al.
Pageof 3